Literature DB >> 10328867

Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution.

F Gouin1, S Couillaud, M Cottrel, A Godard, N Passuti, D Heymann.   

Abstract

The behaviour of multinucleated giant cells (MNC) obtained from a giant cell tumour of the tibia and cultured on glass coverslips or on devitalized dentin slices was investigated using light and electron microscopy. Cells were studied in the presence or absence of LIF a cytokine known to be involved in bone turnover and to act as a growth factor in some solid tumours. The direct effect of LIF on MNC was examined by a post-embedding colloidal gold immunocytochemistry process using human anti-LIF and anti-LIF-receptor (chain gp190) antibodies. After 7 days of culture, the MNC obtained displayed osteoclast immunocytochemical features. Moreover, these MNC were able to resorb large amounts of dentin and presented typical features of active osteoclasts. Immunolocalization of LIF and LIF-receptor revealed the presence of this cytokine and its receptor within the cytoplasm and nucleus of active resorbing MNC. LIF upmodulated MNC number and nucleation but decreased their ability to resorb dentin. The present study suggests that MNC obtained from human GCT, currently considered as osteoclast-like cells, are targets for LIF and may be a source of LIF production in this pathological condition. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328867     DOI: 10.1006/cyto.1998.0429

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  8 in total

1.  Proteoglycans and osteolysis.

Authors:  Marc Baud'Huin; Céline Charrier; Gwenola Bougras; Régis Brion; Frédéric Lezot; Marc Padrines; Dominique Heymann
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

3.  Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats.

Authors:  Stephanie M Davis; Lisa A Collier; Sarah Goodwin; Douglas E Lukins; David K Powell; Keith R Pennypacker
Journal:  Brain Res       Date:  2018-11-13       Impact factor: 3.252

4.  Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways.

Authors:  Natalie A Sims; Brendan J Jenkins; Julian M W Quinn; Akira Nakamura; Markus Glatt; Matthew T Gillespie; Matthias Ernst; T John Martin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

5.  Expression of LIF and LIFR in periodontal tissue during orthodontic tooth movement.

Authors:  Youde Liang; Yi Zhou; Tao Jiang; Zhen Zhang; Su Wang; Yining Wang
Journal:  Angle Orthod       Date:  2011-03-25       Impact factor: 2.079

6.  Alterations in the expression of leukemia inhibitory factor following exercise: comparisons between wild-type and mdx muscles.

Authors:  Liam C Hunt; Chantal Anthea Coles; Christopher M Gorman; Elizabeth M Tudor; Gayle M Smythe; Jason D White
Journal:  PLoS Curr       Date:  2011-11-22

7.  Osteoblast and Osteoclast Activity Affect Bone Remodeling Upon Regulation by Mechanical Loading-Induced Leukemia Inhibitory Factor Expression in Osteocytes.

Authors:  Jingke Du; Jiancheng Yang; Zihao He; Junqi Cui; Yiqi Yang; Mingming Xu; Xinhua Qu; Ning Zhao; Mengning Yan; Hanjun Li; Zhifeng Yu
Journal:  Front Mol Biosci       Date:  2020-11-26

8.  Leukemia Inhibitory Factor Protects Neurons from Ischemic Damage via Upregulation of Superoxide Dismutase 3.

Authors:  Stephanie M Davis; Lisa A Collier; Christopher C Leonardo; Hilary A Seifert; Craig T Ajmo; Keith R Pennypacker
Journal:  Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.